Cargando…
Cyclophosphamide/docetaxel/pegfilgrastim: Various toxicities: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360785/ http://dx.doi.org/10.1007/s40278-021-00609-x |
Ejemplares similares
-
Carnitine/cyclophosphamide/lactulose: Various toxicities: case report
Publicado: (2019) -
Docetaxel/gemcitabine: Various toxicities: 4 case reports
Publicado: (2021) -
Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2020) -
Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021) -
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)